Ad
related to: biogen inc
Search results
Biogen and Ionis halt ALS drug development after trial setback By Investing.com
Investing.com· 4 days agoBiogen Inc. (NASDAQ:BIIB) and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) have announced the...
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic...
Morningstar· 4 days agoBiogen Inc. (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced the decision to terminate development of BIIB105 (ION541) an investigational ...
Press Releases
Morning Times· 5 days agoMay 14, 2024 Facebook Twitter WhatsApp SMS Email TOKYO and CAMBRIDGE, Mass., May 14, 2024 /PRNewswire/ -- Eisai Co., Ltd...
Ionis, Biogen Down on Ending Development of ALS Drug - Biogen (NASDAQ:BIIB), Heron Therapeutics...
Benzinga· 3 days agoShares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market...
Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
Zacks via Yahoo Finance· 5 days agoBiogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA...
Biogen and Ionis Pharma shares slide as they end development of ALS treatment
Morningstar· 4 days agoThe stocks of Biogen Inc. and Ionis Pharmaceuticals Inc. were lower Thursday, after the partners said they were terminating development of a treatment for ...
15 Most Depressed States in the US
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we will be taking a look at the 15 most depressed states in the US. If you are not interested in learning about the global and regional...
Biogen, Ionis to discontinue development of ALS drug
Reuters· 4 days ago, opens new tab said on Thursday they will terminate the development of their experimental treatment for amyotrophic lateral sclerosis (ALS) after...
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for...
NBC 17 Raleigh· 6 days agoEisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher ...
Biogen CEO Looks for Small Deals While Alzheimer’s Drug Ramps Up
Bloomberg· 4 days agoHave a confidential tip for our reporters? Biogen Inc.’s Chief Executive Officer is searching for...
